

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.52729516 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.51400332 |
| 3 | vocalization behavior (GO:0071625) | 5.45643879 |
| 4 | sodium ion export (GO:0071436) | 5.42036134 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.20221160 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.18608368 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.09088631 |
| 8 | protein localization to synapse (GO:0035418) | 5.04846470 |
| 9 | glutamate secretion (GO:0014047) | 5.04807667 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.98847980 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.83548334 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.79099129 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.71120210 |
| 14 | locomotory exploration behavior (GO:0035641) | 4.69837867 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.48310238 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.40977186 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.39491656 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.38720394 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.37786185 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.35306688 |
| 21 | L-amino acid import (GO:0043092) | 4.33163829 |
| 22 | exploration behavior (GO:0035640) | 4.28627079 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.27420693 |
| 24 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.26211475 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21069134 |
| 26 | potassium ion homeostasis (GO:0055075) | 4.16049861 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.07476383 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.05016364 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.04216373 |
| 30 | neuron recognition (GO:0008038) | 4.00533685 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.00179199 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.98737088 |
| 33 | presynaptic membrane assembly (GO:0097105) | 3.93409355 |
| 34 | potassium ion import (GO:0010107) | 3.89853443 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86482330 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.79877327 |
| 37 | amino acid import (GO:0043090) | 3.78588009 |
| 38 | cell communication by electrical coupling (GO:0010644) | 3.73340507 |
| 39 | postsynaptic membrane organization (GO:0001941) | 3.72703796 |
| 40 | cellular sodium ion homeostasis (GO:0006883) | 3.72028436 |
| 41 | regulation of synapse structural plasticity (GO:0051823) | 3.71275441 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.70339060 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70333568 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.68278370 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.66200419 |
| 46 | long-term synaptic potentiation (GO:0060291) | 3.64362040 |
| 47 | presynaptic membrane organization (GO:0097090) | 3.62472725 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.60495625 |
| 49 | response to histamine (GO:0034776) | 3.59629795 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.57175984 |
| 51 | neuronal ion channel clustering (GO:0045161) | 3.56742109 |
| 52 | long-term memory (GO:0007616) | 3.56258126 |
| 53 | proline transport (GO:0015824) | 3.56115651 |
| 54 | axonal fasciculation (GO:0007413) | 3.55729395 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.54145469 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.53267978 |
| 57 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.49749275 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.48899243 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.46058068 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.45627658 |
| 61 | regulation of vesicle fusion (GO:0031338) | 3.44470920 |
| 62 | transmission of nerve impulse (GO:0019226) | 3.42956842 |
| 63 | neurotransmitter uptake (GO:0001504) | 3.42899508 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42725352 |
| 65 | neurotransmitter transport (GO:0006836) | 3.41692782 |
| 66 | regulation of glutamate secretion (GO:0014048) | 3.38019751 |
| 67 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36647421 |
| 68 | central nervous system myelination (GO:0022010) | 3.36034004 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.36034004 |
| 70 | regulation of synapse maturation (GO:0090128) | 3.36016262 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33196907 |
| 72 | behavioral response to cocaine (GO:0048148) | 3.31916671 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.31907189 |
| 74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31891538 |
| 75 | neuromuscular process controlling balance (GO:0050885) | 3.30661856 |
| 76 | activation of protein kinase A activity (GO:0034199) | 3.28417328 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.28097288 |
| 78 | gamma-aminobutyric acid transport (GO:0015812) | 3.27841904 |
| 79 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.26158560 |
| 80 | behavioral defense response (GO:0002209) | 3.24463667 |
| 81 | behavioral fear response (GO:0001662) | 3.24463667 |
| 82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24254296 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 3.23583887 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 3.20988454 |
| 85 | fear response (GO:0042596) | 3.19752596 |
| 86 | * regulation of voltage-gated calcium channel activity (GO:1901385) | 3.16313796 |
| 87 | synapse assembly (GO:0007416) | 3.13832410 |
| 88 | response to auditory stimulus (GO:0010996) | 3.13308533 |
| 89 | regulation of neurotransmitter transport (GO:0051588) | 3.12424794 |
| 90 | membrane depolarization (GO:0051899) | 3.11503067 |
| 91 | innervation (GO:0060384) | 3.11363057 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 3.11139863 |
| 93 | acidic amino acid transport (GO:0015800) | 3.10206755 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 3.09892314 |
| 95 | regulation of dendritic spine development (GO:0060998) | 3.09706175 |
| 96 | vesicle transport along microtubule (GO:0047496) | 3.09068109 |
| 97 | learning (GO:0007612) | 3.07305902 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 3.02709338 |
| 99 | neuromuscular synaptic transmission (GO:0007274) | 3.02624305 |
| 100 | neuromuscular process controlling posture (GO:0050884) | 3.02144927 |
| 101 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00533685 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.00044669 |
| 103 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98373686 |
| 104 | negative regulation of microtubule polymerization (GO:0031115) | 2.97977262 |
| 105 | * synaptic transmission (GO:0007268) | 2.97118698 |
| 106 | serotonin metabolic process (GO:0042428) | 2.96219733 |
| 107 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.95480727 |
| 108 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.95480727 |
| 109 | regulation of synaptic transmission (GO:0050804) | 2.94915205 |
| 110 | mating behavior (GO:0007617) | 2.94704965 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91723835 |
| 112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91141333 |
| 113 | organelle transport along microtubule (GO:0072384) | 2.90803782 |
| 114 | synaptic vesicle transport (GO:0048489) | 2.90511244 |
| 115 | establishment of synaptic vesicle localization (GO:0097480) | 2.90511244 |
| 116 | regulation of protein kinase A signaling (GO:0010738) | 2.90316933 |
| 117 | long term synaptic depression (GO:0060292) | 2.89681275 |
| 118 | vesicle docking involved in exocytosis (GO:0006904) | 2.89370656 |
| 119 | signal release (GO:0023061) | 2.89303240 |
| 120 | positive regulation of synaptic transmission (GO:0050806) | 2.88897554 |
| 121 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87837948 |
| 122 | social behavior (GO:0035176) | 2.87521692 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.87521692 |
| 124 | female mating behavior (GO:0060180) | 2.87420400 |
| 125 | membrane hyperpolarization (GO:0060081) | 2.86608438 |
| 126 | dendritic spine organization (GO:0097061) | 2.86092354 |
| 127 | positive regulation of dendritic spine development (GO:0060999) | 2.86079756 |
| 128 | auditory behavior (GO:0031223) | 2.86010905 |
| 129 | startle response (GO:0001964) | 2.85806791 |
| 130 | positive regulation of synapse assembly (GO:0051965) | 2.84336872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08719127 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.04312385 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21262259 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12235108 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08112556 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.74090766 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69980415 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64044655 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64044655 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59116487 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53321033 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50326901 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49987399 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47017577 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46084458 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40528228 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31394592 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30710190 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15887943 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12780186 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11427808 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09065308 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08579474 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08042885 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04917357 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04878710 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04034682 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96889505 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84030513 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83263330 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83122075 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79088509 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76353656 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.70305832 |
| 35 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.63114512 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62160595 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60122157 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57284370 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56829262 |
| 40 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54686511 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54084668 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53996281 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52240519 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51523304 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50385628 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49968664 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47894644 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47258426 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43865015 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40650750 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40521894 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40367331 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40236552 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37792787 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37669253 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36092055 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32497555 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31515564 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31286491 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28652430 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27553975 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25684659 |
| 63 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22778919 |
| 64 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22775569 |
| 65 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22615073 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21669615 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21505293 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19480901 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18815317 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17562371 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16666634 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16403442 |
| 73 | JUN_21703547_ChIP-Seq_K562_Human | 1.16351906 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12027883 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11872267 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11799955 |
| 77 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09277589 |
| 78 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09106034 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08960871 |
| 80 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05770153 |
| 81 | * AR_19668381_ChIP-Seq_PC3_Human | 1.05488533 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05119336 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03578150 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03255472 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02953184 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02749796 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02628578 |
| 88 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00768498 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00694568 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00641397 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98524686 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98524686 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98370619 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96371721 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96297346 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96016050 |
| 97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95838063 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94020014 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93239134 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92970027 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92925071 |
| 102 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91342801 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91331891 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89439432 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88446051 |
| 106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88418546 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88094374 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87320702 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84924033 |
| 110 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.83115860 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82900511 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.81895823 |
| 113 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80901295 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80539589 |
| 115 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79433308 |
| 116 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.79015982 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78685795 |
| 118 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77780976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.86364868 |
| 2 | MP0003880_abnormal_central_pattern | 5.47659775 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.08580301 |
| 4 | MP0004270_analgesia | 3.88344880 |
| 5 | MP0009745_abnormal_behavioral_response | 3.49457862 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.35588758 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.31438756 |
| 8 | MP0002064_seizures | 3.15998168 |
| 9 | MP0009046_muscle_twitch | 3.03121644 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.88979141 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.82913758 |
| 12 | MP0002736_abnormal_nociception_after | 2.73698124 |
| 13 | MP0002272_abnormal_nervous_system | 2.62432476 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.60211638 |
| 15 | MP0002822_catalepsy | 2.55738749 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.47162705 |
| 17 | MP0001486_abnormal_startle_reflex | 2.40125958 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.38094913 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.35316158 |
| 20 | MP0001984_abnormal_olfaction | 2.32446953 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.18270231 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.16369092 |
| 23 | MP0001970_abnormal_pain_threshold | 2.12908149 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.07010635 |
| 25 | MP0002184_abnormal_innervation | 2.01585295 |
| 26 | MP0000778_abnormal_nervous_system | 2.00064699 |
| 27 | MP0003329_amyloid_beta_deposits | 1.99982108 |
| 28 | MP0001529_abnormal_vocalization | 1.87991398 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.87033143 |
| 30 | MP0004924_abnormal_behavior | 1.87033143 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.75576478 |
| 32 | MP0003690_abnormal_glial_cell | 1.74109685 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.68575029 |
| 34 | MP0001905_abnormal_dopamine_level | 1.65119647 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.64969966 |
| 36 | MP0003879_abnormal_hair_cell | 1.58037883 |
| 37 | MP0008569_lethality_at_weaning | 1.57516857 |
| 38 | MP0004858_abnormal_nervous_system | 1.54401219 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.48471788 |
| 40 | MP0000955_abnormal_spinal_cord | 1.48125880 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.48004622 |
| 42 | MP0001188_hyperpigmentation | 1.47488391 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.41313113 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.40381397 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.34268493 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.32629072 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.26318484 |
| 48 | MP0003633_abnormal_nervous_system | 1.24625966 |
| 49 | MP0003787_abnormal_imprinting | 1.21788250 |
| 50 | MP0004142_abnormal_muscle_tone | 1.21583402 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.17905780 |
| 52 | MP0003631_nervous_system_phenotype | 1.08919278 |
| 53 | MP0003123_paternal_imprinting | 1.07716503 |
| 54 | MP0004742_abnormal_vestibular_system | 1.07208244 |
| 55 | MP0002152_abnormal_brain_morphology | 1.06288209 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.00708003 |
| 57 | MP0003122_maternal_imprinting | 1.00674388 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.99701150 |
| 59 | MP0004885_abnormal_endolymph | 0.99444451 |
| 60 | MP0002229_neurodegeneration | 0.99059113 |
| 61 | MP0008872_abnormal_physiological_respon | 0.96513169 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.95703842 |
| 63 | MP0005499_abnormal_olfactory_system | 0.95412170 |
| 64 | MP0005394_taste/olfaction_phenotype | 0.95412170 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.95249968 |
| 66 | MP0000604_amyloidosis | 0.94489594 |
| 67 | MP0001963_abnormal_hearing_physiology | 0.89817818 |
| 68 | MP0004147_increased_porphyrin_level | 0.89523803 |
| 69 | MP0008874_decreased_physiological_sensi | 0.89430032 |
| 70 | MP0004484_altered_response_of | 0.86404543 |
| 71 | MP0002069_abnormal_eating/drinking_beha | 0.86122628 |
| 72 | MP0005535_abnormal_body_temperature | 0.83651089 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.83638327 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.82782556 |
| 75 | MP0003634_abnormal_glial_cell | 0.80556560 |
| 76 | MP0008877_abnormal_DNA_methylation | 0.80248371 |
| 77 | MP0005409_darkened_coat_color | 0.77790305 |
| 78 | MP0000751_myopathy | 0.77692284 |
| 79 | MP0004085_abnormal_heartbeat | 0.76419267 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.72707484 |
| 81 | MP0001664_abnormal_digestion | 0.72136368 |
| 82 | MP0004510_myositis | 0.72110622 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.71971628 |
| 84 | MP0003632_abnormal_nervous_system | 0.71521674 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.71269431 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.70973761 |
| 87 | MP0000920_abnormal_myelination | 0.69056410 |
| 88 | MP0004043_abnormal_pH_regulation | 0.67617762 |
| 89 | MP0002090_abnormal_vision | 0.66939355 |
| 90 | MP0005171_absent_coat_pigmentation | 0.65873737 |
| 91 | MP0001177_atelectasis | 0.64164334 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.63216989 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.63138787 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.60992619 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.60821754 |
| 96 | MP0005187_abnormal_penis_morphology | 0.59638669 |
| 97 | MP0005166_decreased_susceptibility_to | 0.59345959 |
| 98 | MP0005623_abnormal_meninges_morphology | 0.58341815 |
| 99 | MP0000026_abnormal_inner_ear | 0.57910720 |
| 100 | MP0004130_abnormal_muscle_cell | 0.55080923 |
| 101 | MP0001943_abnormal_respiration | 0.54595954 |
| 102 | MP0003283_abnormal_digestive_organ | 0.54554846 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.54507032 |
| 104 | MP0002163_abnormal_gland_morphology | 0.52403097 |
| 105 | MP0003121_genomic_imprinting | 0.51377556 |
| 106 | MP0010769_abnormal_survival | 0.51053873 |
| 107 | MP0003861_abnormal_nervous_system | 0.49853543 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.49791614 |
| 109 | MP0005410_abnormal_fertilization | 0.49368321 |
| 110 | MP0002653_abnormal_ependyma_morphology | 0.49161336 |
| 111 | MP0003956_abnormal_body_size | 0.48031002 |
| 112 | MP0010768_mortality/aging | 0.47861574 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.46991682 |
| 114 | MP0003075_altered_response_to | 0.46931159 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.45411295 |
| 116 | MP0002082_postnatal_lethality | 0.44413754 |
| 117 | MP0010770_preweaning_lethality | 0.44413754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.69501144 |
| 2 | Myokymia (HP:0002411) | 6.30738612 |
| 3 | Focal seizures (HP:0007359) | 5.65051509 |
| 4 | Visual hallucinations (HP:0002367) | 5.33890546 |
| 5 | Atonic seizures (HP:0010819) | 5.25415799 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.13271653 |
| 7 | Absence seizures (HP:0002121) | 4.59516564 |
| 8 | Febrile seizures (HP:0002373) | 4.50353790 |
| 9 | Hyperventilation (HP:0002883) | 4.23791429 |
| 10 | Dialeptic seizures (HP:0011146) | 4.21375135 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.98202920 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.79422236 |
| 13 | Broad-based gait (HP:0002136) | 3.73589808 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.58100260 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.55792945 |
| 16 | Hemiplegia (HP:0002301) | 3.53887815 |
| 17 | Amblyopia (HP:0000646) | 3.45712478 |
| 18 | Action tremor (HP:0002345) | 3.22150962 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.18540821 |
| 20 | Poor eye contact (HP:0000817) | 3.07148368 |
| 21 | Truncal ataxia (HP:0002078) | 3.02531966 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.02530221 |
| 23 | Anxiety (HP:0000739) | 2.99170677 |
| 24 | Tetraplegia (HP:0002445) | 2.96800180 |
| 25 | Mutism (HP:0002300) | 2.94908147 |
| 26 | Insidious onset (HP:0003587) | 2.91485864 |
| 27 | Termporal pattern (HP:0011008) | 2.91485864 |
| 28 | Excessive salivation (HP:0003781) | 2.89603652 |
| 29 | Drooling (HP:0002307) | 2.89603652 |
| 30 | Cerebral hypomyelination (HP:0006808) | 2.85880438 |
| 31 | Status epilepticus (HP:0002133) | 2.85840120 |
| 32 | Dysmetria (HP:0001310) | 2.85384483 |
| 33 | Obstructive sleep apnea (HP:0002870) | 2.78753132 |
| 34 | Limb dystonia (HP:0002451) | 2.77927049 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.77539813 |
| 36 | Dysdiadochokinesis (HP:0002075) | 2.75345233 |
| 37 | Depression (HP:0000716) | 2.75233557 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.72029889 |
| 39 | Progressive inability to walk (HP:0002505) | 2.71635087 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71110424 |
| 41 | Ankle clonus (HP:0011448) | 2.70466944 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.70022934 |
| 43 | Gait imbalance (HP:0002141) | 2.67723529 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.66951829 |
| 45 | Diplopia (HP:0000651) | 2.66391396 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.66391396 |
| 47 | Abnormal social behavior (HP:0012433) | 2.65685145 |
| 48 | Impaired social interactions (HP:0000735) | 2.65685145 |
| 49 | Inability to walk (HP:0002540) | 2.62628648 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.62357576 |
| 51 | Pheochromocytoma (HP:0002666) | 2.62065536 |
| 52 | Papilledema (HP:0001085) | 2.55450879 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53786423 |
| 54 | Delusions (HP:0000746) | 2.49766773 |
| 55 | Annular pancreas (HP:0001734) | 2.45707409 |
| 56 | Absent speech (HP:0001344) | 2.45263107 |
| 57 | Sleep apnea (HP:0010535) | 2.39178427 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.38812052 |
| 59 | Polyphagia (HP:0002591) | 2.37851305 |
| 60 | Ventricular fibrillation (HP:0001663) | 2.36812843 |
| 61 | Hemiparesis (HP:0001269) | 2.35844503 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.35635871 |
| 63 | Scanning speech (HP:0002168) | 2.34364857 |
| 64 | Stereotypic behavior (HP:0000733) | 2.33021882 |
| 65 | Retinal dysplasia (HP:0007973) | 2.32354019 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.32339871 |
| 67 | Impaired smooth pursuit (HP:0007772) | 2.31012683 |
| 68 | Increased circulating renin level (HP:0000848) | 2.30565012 |
| 69 | Amyotrophic lateral sclerosis (HP:0007354) | 2.29772299 |
| 70 | Urinary urgency (HP:0000012) | 2.28633773 |
| 71 | Fetal akinesia sequence (HP:0001989) | 2.28539845 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.27846000 |
| 73 | Clonus (HP:0002169) | 2.27179982 |
| 74 | Spastic gait (HP:0002064) | 2.26591837 |
| 75 | Rigidity (HP:0002063) | 2.22620153 |
| 76 | Medial flaring of the eyebrow (HP:0010747) | 2.19335278 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.17571119 |
| 78 | Congenital primary aphakia (HP:0007707) | 2.17321400 |
| 79 | Bradykinesia (HP:0002067) | 2.14768673 |
| 80 | Genetic anticipation (HP:0003743) | 2.14491326 |
| 81 | Diminished motivation (HP:0000745) | 2.13992102 |
| 82 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13926662 |
| 83 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13926662 |
| 84 | Torticollis (HP:0000473) | 2.13290087 |
| 85 | Peripheral hypomyelination (HP:0007182) | 2.12086309 |
| 86 | Spastic tetraparesis (HP:0001285) | 2.11850258 |
| 87 | Abnormal ciliary motility (HP:0012262) | 2.11526034 |
| 88 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10911497 |
| 89 | Abnormality of salivation (HP:0100755) | 2.08992971 |
| 90 | Agitation (HP:0000713) | 2.08444016 |
| 91 | Focal dystonia (HP:0004373) | 2.06744185 |
| 92 | Akinesia (HP:0002304) | 2.06223513 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.05368223 |
| 94 | Absent/shortened dynein arms (HP:0200106) | 2.05209622 |
| 95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05209622 |
| 96 | Postural instability (HP:0002172) | 2.02924828 |
| 97 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.02480877 |
| 98 | Protruding tongue (HP:0010808) | 2.01755335 |
| 99 | Inappropriate behavior (HP:0000719) | 2.01598816 |
| 100 | Hyperthyroidism (HP:0000836) | 2.00508994 |
| 101 | Lower limb muscle weakness (HP:0007340) | 2.00319329 |
| 102 | Bundle branch block (HP:0011710) | 1.97228440 |
| 103 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95177263 |
| 104 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95177263 |
| 105 | Psychosis (HP:0000709) | 1.94739176 |
| 106 | Megalencephaly (HP:0001355) | 1.94250934 |
| 107 | Split foot (HP:0001839) | 1.94248836 |
| 108 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94246831 |
| 109 | Blue irides (HP:0000635) | 1.93892650 |
| 110 | Incomplete penetrance (HP:0003829) | 1.93482575 |
| 111 | Memory impairment (HP:0002354) | 1.89989455 |
| 112 | Mitochondrial inheritance (HP:0001427) | 1.89612357 |
| 113 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89423949 |
| 114 | Impaired vibratory sensation (HP:0002495) | 1.88307512 |
| 115 | Specific learning disability (HP:0001328) | 1.87943562 |
| 116 | Craniofacial dystonia (HP:0012179) | 1.86361236 |
| 117 | Intention tremor (HP:0002080) | 1.86045223 |
| 118 | Choreoathetosis (HP:0001266) | 1.85805109 |
| 119 | CNS hypomyelination (HP:0003429) | 1.85422931 |
| 120 | Prolonged QT interval (HP:0001657) | 1.83916224 |
| 121 | Abnormality of the lower motor neuron (HP:0002366) | 1.82878425 |
| 122 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.82618063 |
| 123 | Apathy (HP:0000741) | 1.82613829 |
| 124 | Rapidly progressive (HP:0003678) | 1.82442624 |
| 125 | Genital tract atresia (HP:0001827) | 1.82155881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.14661084 |
| 2 | NTRK3 | 4.07517193 |
| 3 | MAP3K9 | 3.54274501 |
| 4 | MARK1 | 3.32377337 |
| 5 | MAP3K4 | 3.09039601 |
| 6 | MAP3K12 | 3.01327617 |
| 7 | CASK | 3.01021487 |
| 8 | MAP2K7 | 2.86658894 |
| 9 | MINK1 | 2.75773819 |
| 10 | RIPK4 | 2.71425792 |
| 11 | DAPK2 | 2.38222014 |
| 12 | PNCK | 2.23716820 |
| 13 | PLK2 | 2.18171187 |
| 14 | ARAF | 2.01450689 |
| 15 | GRK5 | 1.96023790 |
| 16 | MAP2K4 | 1.93969535 |
| 17 | KSR2 | 1.89408752 |
| 18 | NTRK1 | 1.85828429 |
| 19 | DAPK1 | 1.82497768 |
| 20 | NTRK2 | 1.66837268 |
| 21 | PINK1 | 1.66279725 |
| 22 | PAK6 | 1.60583338 |
| 23 | KSR1 | 1.59220963 |
| 24 | CDK19 | 1.56456992 |
| 25 | CDK5 | 1.42490704 |
| 26 | MAPK13 | 1.39235375 |
| 27 | BMPR2 | 1.34359197 |
| 28 | NME1 | 1.34347205 |
| 29 | TNIK | 1.32848810 |
| 30 | RIPK1 | 1.27490213 |
| 31 | PRKCG | 1.23606078 |
| 32 | PTK2B | 1.23434576 |
| 33 | CAMKK1 | 1.22868783 |
| 34 | FES | 1.18189954 |
| 35 | SIK2 | 1.15106060 |
| 36 | TESK1 | 1.14871630 |
| 37 | MAP3K2 | 1.14568626 |
| 38 | CAMK2A | 1.14102555 |
| 39 | LIMK1 | 1.13926663 |
| 40 | CAMKK2 | 1.12962471 |
| 41 | PRPF4B | 1.10112311 |
| 42 | OXSR1 | 1.06782306 |
| 43 | FGR | 1.05804120 |
| 44 | MAP3K13 | 1.03840356 |
| 45 | CAMK2B | 1.03555300 |
| 46 | PHKG2 | 0.97773227 |
| 47 | PHKG1 | 0.97773227 |
| 48 | RAF1 | 0.93344722 |
| 49 | CDK14 | 0.91363662 |
| 50 | LATS2 | 0.88960223 |
| 51 | CDK18 | 0.87988016 |
| 52 | NEK6 | 0.86144392 |
| 53 | UHMK1 | 0.83131971 |
| 54 | CDK15 | 0.83092573 |
| 55 | PRKD3 | 0.83014210 |
| 56 | BCR | 0.81336752 |
| 57 | CCNB1 | 0.77416047 |
| 58 | CSNK1G2 | 0.76068595 |
| 59 | DYRK1A | 0.75445714 |
| 60 | PAK3 | 0.75148920 |
| 61 | GRK7 | 0.74977554 |
| 62 | CDK11A | 0.72317014 |
| 63 | PRKCE | 0.71377643 |
| 64 | SGK3 | 0.70425748 |
| 65 | CAMK2D | 0.65813966 |
| 66 | STK38 | 0.64986211 |
| 67 | STK11 | 0.64045123 |
| 68 | SGK223 | 0.62558529 |
| 69 | SGK494 | 0.62558529 |
| 70 | RET | 0.61798722 |
| 71 | SIK3 | 0.61795321 |
| 72 | TYRO3 | 0.60766966 |
| 73 | ALK | 0.57197544 |
| 74 | GRK6 | 0.57033703 |
| 75 | FER | 0.56333209 |
| 76 | SGK1 | 0.54727774 |
| 77 | BRAF | 0.54360046 |
| 78 | CAMK4 | 0.54317963 |
| 79 | CAMK1 | 0.54114680 |
| 80 | MAPK10 | 0.53668785 |
| 81 | STK39 | 0.53410969 |
| 82 | CAMK2G | 0.51328384 |
| 83 | MAP3K6 | 0.50772155 |
| 84 | DAPK3 | 0.47662336 |
| 85 | PRKCZ | 0.47466102 |
| 86 | ADRBK1 | 0.47183737 |
| 87 | MAPK15 | 0.47069052 |
| 88 | ROCK2 | 0.46033014 |
| 89 | MAP2K1 | 0.46006864 |
| 90 | MAP3K11 | 0.44564207 |
| 91 | FYN | 0.44224665 |
| 92 | AKT3 | 0.42155697 |
| 93 | PRKCA | 0.41878791 |
| 94 | PDPK1 | 0.41680122 |
| 95 | MAP3K1 | 0.41218579 |
| 96 | MARK2 | 0.40790811 |
| 97 | SGK2 | 0.40097154 |
| 98 | PRKG1 | 0.39399117 |
| 99 | PDK1 | 0.39376986 |
| 100 | ROCK1 | 0.39161306 |
| 101 | CSNK1A1L | 0.38390385 |
| 102 | MAPK12 | 0.37711345 |
| 103 | MOS | 0.37044968 |
| 104 | MAP2K6 | 0.36854042 |
| 105 | PRKCH | 0.36705640 |
| 106 | FGFR2 | 0.36557297 |
| 107 | PKN1 | 0.34136465 |
| 108 | TNK2 | 0.32929021 |
| 109 | CSNK1G3 | 0.31674014 |
| 110 | SCYL2 | 0.31434495 |
| 111 | PRKACA | 0.31249331 |
| 112 | ADRBK2 | 0.30809548 |
| 113 | RPS6KA3 | 0.30689392 |
| 114 | CSNK1D | 0.30133720 |
| 115 | ERBB3 | 0.30085439 |
| 116 | DYRK2 | 0.29216373 |
| 117 | WNK3 | 0.29159910 |
| 118 | PRKCB | 0.28596469 |
| 119 | TAOK1 | 0.28038788 |
| 120 | ERBB2 | 0.27841064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83754625 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.40424812 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87109892 |
| 4 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.82649007 |
| 5 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.72540655 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61087540 |
| 7 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.57855055 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.56092021 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.53618290 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38834710 |
| 11 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.38193755 |
| 12 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21281665 |
| 13 | * Salivary secretion_Homo sapiens_hsa04970 | 2.05826590 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04934046 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.02478405 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91337230 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.90568752 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88977106 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.84970465 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.81600047 |
| 21 | * Renin secretion_Homo sapiens_hsa04924 | 1.80050862 |
| 22 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.73988922 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63517994 |
| 24 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59849852 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55862604 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55310178 |
| 27 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53841723 |
| 28 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53622951 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48565649 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47200254 |
| 31 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43952348 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41840605 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.34299143 |
| 34 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32972607 |
| 35 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25699221 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.18005343 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16859428 |
| 38 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12740999 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10865922 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08835720 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06175659 |
| 42 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05396458 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96675153 |
| 44 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95691766 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95222555 |
| 46 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94555245 |
| 47 | * Melanogenesis_Homo sapiens_hsa04916 | 0.94022943 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90869249 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88500664 |
| 50 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88356092 |
| 51 | * Glioma_Homo sapiens_hsa05214 | 0.84720962 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84283725 |
| 53 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.82648524 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82634206 |
| 55 | * Phototransduction_Homo sapiens_hsa04744 | 0.81705262 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.76324153 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73480724 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71096477 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69871062 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69768595 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66786045 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66404322 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65404034 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63834811 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61117920 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60921238 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60692669 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58922431 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57721243 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56197904 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55446729 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55295168 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55002153 |
| 74 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.53692691 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53094652 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.52476317 |
| 77 | * Alcoholism_Homo sapiens_hsa05034 | 0.50379616 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48476245 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48374335 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46810622 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42279476 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.42236257 |
| 83 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42226361 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40895264 |
| 85 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40234368 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.40165545 |
| 87 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40029170 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38962211 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38861285 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38360082 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.37573403 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37343319 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36980739 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35638223 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34530740 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.33787849 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33486013 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32138203 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31431342 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31419996 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30883898 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29130319 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29017519 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27651808 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26867685 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25846836 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.25660052 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23377154 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22873344 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.22448513 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22328429 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21902892 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21713728 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.19934186 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19882675 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18623147 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16850112 |

